Patient-Reported Outcomes and Quality of Life Improved with Fluticasone Propionate and Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhalers Versus Placebo in Patients with Persistent Asthma

被引：1
|
作者：
Raphael, Gordon [1 ]
Yiu, Gloria [2 ]
Sakov, Anat [3 ]
Liu, Siyu [2 ]
Caracta, Cynthia [2 ]
机构：
[1] Bethesda Allergy Asthma & Res Ctr, Bethesda, MD USA
[2] Teva Pharmaceut, Frazer, PA USA
[3] Teva Pharmaceut, Netanya, Israel
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.086
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
31
引用
收藏
页码：AB10 / AB10
页数：1
相关论文
共 50 条
  • [31] Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
    van Noord, JA
    Schreurs, AJM
    Mol, SJM
    Mulder, PGH
    THORAX, 1999, 54 (03) : 207 - 212
  • [32] Improved ability to perform strenuous activities after treatment with fluticasone propionate/salmeterol combination in patients with persistent asthma
    Nathan, RA
    Dorinsky, P
    Rosenzweig, JRC
    Shah, T
    Edin, H
    Prillaman, B
    JOURNAL OF ASTHMA, 2003, 40 (07) : 815 - 822
  • [33] Difference between patient-reported side effects of ciclesonide versus fluticasone propionate
    van der Molen, Thys
    Foster, Juliet M.
    Caeser, Manfred
    Muller, Thomas
    Postma, Dirkje S.
    RESPIRATORY MEDICINE, 2010, 104 (12) : 1825 - 1833
  • [34] Efficacy of the combination of fluticasone propionate and salmeterol in patients with moderate persistent asthma within a "real-life" setting
    Trautmann, M.
    Banik, N.
    Tews, J. T.
    Joerres, R. A.
    Nowak, D.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (06) : 255 - 263
  • [35] Salmeterol/fluticasone propionate via Diskus™ once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids
    Chuchalin, Alexander
    Jacques, Loretta
    Frith, Lucy
    CLINICAL DRUG INVESTIGATION, 2008, 28 (03) : 169 - 181
  • [36] The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma
    Malone, R
    LaForce, C
    Nimmagadda, S
    Schoaf, L
    House, K
    Ellsworth, A
    Dorinsky, P
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 95 (01) : 66 - 71
  • [37] Salmeterol/Fluticasone Propionate via Diskus™ Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids
    Alexander Chuchalin
    Loretta Jacques
    Lucy Frith
    Clinical Drug Investigation, 2008, 28 : 169 - 181
  • [38] Effect of fluticasone propionate/salmeterol combination product on activity induced bronchospasm in patients with persistent asthma
    Nathan, RA
    Kalberg, C
    Jones, S
    Emmett, A
    Rickard, K
    Dorinsky, PM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S236 - S236
  • [39] Fluticasone propionate/salmeterol combination improves health outcomes and quality of life in children with poorly controlled asthma in Ireland
    Hill, P
    Hughes, J
    Grant, D
    Sawyer, W
    Reeves, P
    VALUE IN HEALTH, 2005, 8 (06) : A30 - A31
  • [40] Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma
    Sheth, K
    Borker, R
    Emmett, A
    Rickard, K
    Dorinsky, P
    PHARMACOECONOMICS, 2002, 20 (13) : 909 - 918
12345